These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 33372952)
1. Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. Li H; Sisoudiya SD; Martin-Giacalone BA; Khayat MM; Dugan-Perez S; Marquez-Do DA; Scheurer ME; Muzny D; Boerwinkle E; Gibbs RA; Chi YY; Barkauskas DA; Lo T; Hall D; Stewart DR; Schiffman JD; Skapek SX; Hawkins DS; Plon SE; Sabo A; Lupo PJ J Natl Cancer Inst; 2021 Jul; 113(7):875-883. PubMed ID: 33372952 [TBL] [Abstract][Full Text] [Related]
2. Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma. Kim J; Light N; Subasri V; Young EL; Wegman-Ostrosky T; Barkauskas DA; Hall D; Lupo PJ; Patidar R; Maese LD; Jones K; Wang M; Tavtigian SV; Wu D; Shlien A; Telfer F; Goldenberg A; Skapek SX; Wei JS; Wen X; Catchpoole D; Hawkins DS; Schiffman JD; Khan J; Malkin D; Stewart DR JCO Precis Oncol; 2021; 5():. PubMed ID: 34095712 [TBL] [Abstract][Full Text] [Related]
4. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity. Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788 [TBL] [Abstract][Full Text] [Related]
5. TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children's Oncology Group report. Fair D; Maese L; Chi YY; Li M; Hawkins DS; Venkatramani R; Rudzinski E; Parham D; Teot L; Malkin D; Plon SE; Li H; Sabo A; Lupo PJ; Schiffman JD Pediatr Blood Cancer; 2023 May; ():e30413. PubMed ID: 37194615 [TBL] [Abstract][Full Text] [Related]
6. Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group. Martin-Giacalone BA; Richard MA; Scheurer ME; Khan J; Sok P; Shetty PB; Chanock SJ; Li SA; Yeager M; Marquez-Do DA; Barkauskas DA; Hall D; McEvoy MT; Brown AL; Sabo A; Scheet P; Huff CD; Skapek SX; Hawkins DS; Venkatramani R; Mirabello L; Lupo PJ J Natl Cancer Inst; 2023 Jun; 115(6):733-741. PubMed ID: 36951526 [TBL] [Abstract][Full Text] [Related]
7. The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer. Escudeiro C; Pinto C; Vieira J; Peixoto A; Pinto P; Pinheiro M; Santos C; Guerra J; Lisboa S; Santos R; Silva J; Leal C; Coimbra N; Lopes P; Ferreira M; Sousa AB; Teixeira MR Fam Cancer; 2021 Jul; 20(3):173-180. PubMed ID: 33051812 [TBL] [Abstract][Full Text] [Related]
8. Rhabdomyosarcoma as the first presentation in Neurofibromatosis Type 1: case series and review of the literature. Castle AMR; Empringham B; Pinto LM; Villani A; Kanwar N; Abbott LS; Sawyer SL Pediatr Hematol Oncol; 2023; 40(5):506-515. PubMed ID: 36625737 [TBL] [Abstract][Full Text] [Related]
9. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil. Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735 [TBL] [Abstract][Full Text] [Related]
10. Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experience. Pondrom M; Bougeard G; Karanian M; Bonneau-Lagacherie J; Boulanger C; Boutroux H; Briandet C; Chevreau C; Corradini N; Coze C; Defachelles AS; Galmiche-Roland L; Orbach D; Piguet C; Scoazec JY; Vérité C; Willems M; Frebourg T; Minard V; Brugières L Pediatr Blood Cancer; 2020 Sep; 67(9):e28486. PubMed ID: 32658383 [TBL] [Abstract][Full Text] [Related]
11. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group. Martin-Giacalone BA; Li H; Scheurer ME; Casey DL; Dugan-Perez S; Marquez-Do DA; Muzny D; Gibbs RA; Barkauskas DA; Hall D; Stewart DR; Schiffman JD; McEvoy MT; Khan J; Malkin D; Linardic CM; Crompton BD; Shern JF; Skapek SX; Venkatramani R; Hawkins DS; Sabo A; Plon SE; Lupo PJ JAMA Netw Open; 2024 Mar; 7(3):e244170. PubMed ID: 38546643 [TBL] [Abstract][Full Text] [Related]
12. Germline cancer predisposition variants and pediatric glioma: a population-based study in California. Muskens IS; de Smith AJ; Zhang C; Hansen HM; Morimoto L; Metayer C; Ma X; Walsh KM; Wiemels JL Neuro Oncol; 2020 Jun; 22(6):864-874. PubMed ID: 31970404 [TBL] [Abstract][Full Text] [Related]
13. Report of 2 Pediatric Cases With Li-Fraumeni Syndrome Related Malignancy in a Family. Takeoka M; Toyoda H; Hirayama J; Suzuki N; Hanaki R; Amano K; Iwamoto S; Hirayama M J Pediatr Hematol Oncol; 2021 May; 43(4):e567-e570. PubMed ID: 32555031 [TBL] [Abstract][Full Text] [Related]
14. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S; JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041 [TBL] [Abstract][Full Text] [Related]
15. A systematic review of the prevalence of pathogenic or likely pathogenic germline variants in individuals with FOXO1 fusion-positive rhabdomyosarcoma. Freycon C; Lupo PJ; Witkowski L; Budd C; Foulkes WD; Goudie C Pediatr Blood Cancer; 2023 Nov; 70(11):e30651. PubMed ID: 37638828 [TBL] [Abstract][Full Text] [Related]
16. Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile. Franceschi S; Spugnesi L; Aretini P; Lessi F; Scarpitta R; Galli A; Congregati C; Caligo MA; Mazzanti CM Carcinogenesis; 2017 Sep; 38(9):938-943. PubMed ID: 28911001 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population. Gallardo-Alvarado LN; Tusié-Luna MT; Tussié-Luna MI; Díaz-Chávez J; Segura YX; Bargallo-Rocha E; Villarreal C; Herrera-Montalvo LA; Herrera-Medina EM; Cantu-de Leon DF BMC Cancer; 2019 Feb; 19(1):118. PubMed ID: 30709381 [TBL] [Abstract][Full Text] [Related]
18. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290 [TBL] [Abstract][Full Text] [Related]
19. Cancer predisposition genes in Japanese children with rhabdomyosarcoma. Fukushima H; Suzuki R; Yamaki Y; Hosaka S; Inaba M; Morii W; Noguchi E; Takada H J Hum Genet; 2022 Jan; 67(1):35-41. PubMed ID: 34257391 [TBL] [Abstract][Full Text] [Related]
20. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]